195 related articles for article (PubMed ID: 32744700)
1. A novel homozygous TPM1 mutation in familial pediatric hypertrophic cardiomyopathy and in silico screening of potential targeting drugs.
Carlus SJ; Almuzaini IS; Karthikeyan M; Loganathan L; Al-Harbi GS; Carlus FH; Al-Mazroea AH; Morsy MM; Abo-Haded HM; Abdallah AM; Al-Harbi KM
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7732-7744. PubMed ID: 32744700
[TBL] [Abstract][Full Text] [Related]
2. Next-generation sequencing identifies a homozygous mutation in ACADVL associated with pediatric familial dilated cardiomyopathy.
Carlus SJ; Almuzaini IS; Karthikeyan M; Loganathan L; Al-Harbi GS; Abdallah AM; Al-Harbi KM
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1710-1721. PubMed ID: 30840296
[TBL] [Abstract][Full Text] [Related]
3. A novel alpha-tropomyosin mutation associates with dilated and non-compaction cardiomyopathy and diminishes actin binding.
van de Meerakker JB; Christiaans I; Barnett P; Lekanne Deprez RH; Ilgun A; Mook OR; Mannens MM; Lam J; Wilde AA; Moorman AF; Postma AV
Biochim Biophys Acta; 2013 Apr; 1833(4):833-9. PubMed ID: 23147248
[TBL] [Abstract][Full Text] [Related]
4. Variable clinical manifestation of a novel missense mutation in the alpha-tropomyosin (TPM1) gene in familial hypertrophic cardiomyopathy.
Jongbloed RJ; Marcelis CL; Doevendans PA; Schmeitz-Mulkens JM; Van Dockum WG; Geraedts JP; Smeets HJ
J Am Coll Cardiol; 2003 Mar; 41(6):981-6. PubMed ID: 12651045
[TBL] [Abstract][Full Text] [Related]
5. Coexistence of Digenic Mutations in Both Thin (TPM1) and Thick (MYH7) Filaments of Sarcomeric Genes Leads to Severe Hypertrophic Cardiomyopathy in a South Indian FHCM.
Selvi Rani D; Nallari P; Dhandapany PS; Rani J; Meraj K; Ganesan M; Narasimhan C; Thangaraj K
DNA Cell Biol; 2015 May; 34(5):350-9. PubMed ID: 25607779
[TBL] [Abstract][Full Text] [Related]
6. Identification of novel mutations including a double mutation in patients with inherited cardiomyopathy by a targeted sequencing approach using the Ion Torrent PGM system.
Zhao Y; Cao H; Song Y; Feng Y; Ding X; Pang M; Zhang Y; Zhang H; Ding J; Xia X
Int J Mol Med; 2016 Jun; 37(6):1511-20. PubMed ID: 27082122
[TBL] [Abstract][Full Text] [Related]
7. Hypertrophic cardiomyopathy caused by a novel alpha-tropomyosin mutation (V95A) is associated with mild cardiac phenotype, abnormal calcium binding to troponin, abnormal myosin cycling, and poor prognosis.
Karibe A; Tobacman LS; Strand J; Butters C; Back N; Bachinski LL; Arai AE; Ortiz A; Roberts R; Homsher E; Fananapazir L
Circulation; 2001 Jan; 103(1):65-71. PubMed ID: 11136687
[TBL] [Abstract][Full Text] [Related]
8. Mutations in
Salazar-Mendiguchía J; Ochoa JP; Palomino-Doza J; Domínguez F; Díez-López C; Akhtar M; Ramiro-León S; Clemente MM; Pérez-Cejas A; Robledo M; Gómez-Díaz I; Peña-Peña ML; Climent V; Salmerón-Martínez F; Hernández C; García-Granja PE; Mogollón MV; Cárdenas-Reyes I; Cicerchia M; García-Giustiniani D; Lamounier A; Gil-Fournier B; Díaz-Flores F; Salguero R; Santomé L; Syrris P; Olivé M; García-Pavía P; Ortiz-Genga M; Elliott PM; Monserrat L;
Heart; 2020 Sep; 106(17):1342-1348. PubMed ID: 32451364
[TBL] [Abstract][Full Text] [Related]
9. Genotype-phenotype correlations in hypertrophic cardiomyopathy: a multicenter study in Portugal and Spain of the TPM1 p.Arg21Leu variant.
Lamounier Junior A; Guitián González A; Rodríguez Vilela A; Repáraz Andrade A; Rubio Alcaide Á; Berta Sousa A; Benito López C; Alonso García D; Fernández Ferro G; Cruz I; Cárdenas Reyes IJ; Salazar-Mendiguchía García J; Larrañaga-Moreira JM; Ochoa JP; Palomino-Doza J; de la Higuera Romero L; Nicolás Cicerchia M; Restrepo Córdoba MA; Peña-Peña ML; Noël Brögger M; Loureiro M; Mogollón Jiménez MV; Bilbao Quesada R; Franco Gutiérrez R; García Hernández S; Ripoll-Vera T; Fernández X; Azevedo O; García Pavía P; Lopes LR; Ortiz M; Brito D; Barriales-Villa R; Monserrat Iglesias L
Rev Esp Cardiol (Engl Ed); 2022 Mar; 75(3):242-250. PubMed ID: 33642254
[TBL] [Abstract][Full Text] [Related]
10. Identification of a novel missense mutation in the TPM1 gene via exome sequencing in a Chinese family with dilated cardiomyopathy: A case report and literature review.
Man Y; Yi C; Fan M; Yang T; Liu P; Liu S; Wang G
Medicine (Baltimore); 2022 Jan; 101(2):e28551. PubMed ID: 35029218
[TBL] [Abstract][Full Text] [Related]
11. A Novel
Kumar P; Paramasivam G; Devasia T; Prabhu M; Rai MK; Prakashini K; Mallya S; Reghunathan D; Megha A; Nayak K; Moka R
Indian J Clin Biochem; 2024 Jan; 39(1):142-145. PubMed ID: 38223010
[TBL] [Abstract][Full Text] [Related]
12. Presence of Hypertrophic Cardiomyopathy Related Gene Mutations and Clinical Manifestations in Vietnamese Patients With Hypertrophic Cardiomyopathy.
Tran Vu MT; Nguyen TV; Huynh NV; Nguyen Thai HT; Pham Nguyen V; Ho Huynh TD
Circ J; 2019 Aug; 83(9):1908-1916. PubMed ID: 31308319
[TBL] [Abstract][Full Text] [Related]
13. Utilization of Whole Exome Sequencing to Identify Causative Mutations in Familial Congenital Heart Disease.
LaHaye S; Corsmeier D; Basu M; Bowman JL; Fitzgerald-Butt S; Zender G; Bosse K; McBride KL; White P; Garg V
Circ Cardiovasc Genet; 2016 Aug; 9(4):320-9. PubMed ID: 27418595
[TBL] [Abstract][Full Text] [Related]
14. Autosomal recessive transmission of MYBPC3 mutation results in malignant phenotype of hypertrophic cardiomyopathy.
Wang Y; Wang Z; Yang Q; Zou Y; Zhang H; Yan C; Feng X; Chen Y; Zhang Y; Wang J; Zhou X; Ahmad F; Hui R; Song L
PLoS One; 2013; 8(6):e67087. PubMed ID: 23840593
[TBL] [Abstract][Full Text] [Related]
15. Somatic MYH7, MYBPC3, TPM1, TNNT2 and TNNI3 mutations in sporadic hypertrophic cardiomyopathy.
Núñez L; Gimeno-Blanes JR; Rodríguez-García MI; Monserrat L; Zorio E; Coats C; McGregor CG; Hernandez del Rincón JP; Castro-Beiras A; Hermida-Prieto M
Circ J; 2013; 77(9):2358-65. PubMed ID: 23782526
[TBL] [Abstract][Full Text] [Related]
16. The effect of tropomyosin variants on cardiomyocyte function and structure that underlie different clinical cardiomyopathy phenotypes.
Dorsch LM; Kuster DWD; Jongbloed JDH; Boven LG; van Spaendonck-Zwarts KY; Suurmeijer AJH; Vink A; du Marchie Sarvaas GJ; van den Berg MP; van der Velden J; Brundel BJJM; van der Zwaag PA
Int J Cardiol; 2021 Jan; 323():251-258. PubMed ID: 32882290
[TBL] [Abstract][Full Text] [Related]
17. Familial dilated cardiomyopathy caused by an alpha-tropomyosin mutation: the distinctive natural history of sarcomeric dilated cardiomyopathy.
Lakdawala NK; Dellefave L; Redwood CS; Sparks E; Cirino AL; Depalma S; Colan SD; Funke B; Zimmerman RS; Robinson P; Watkins H; Seidman CE; Seidman JG; McNally EM; Ho CY
J Am Coll Cardiol; 2010 Jan; 55(4):320-9. PubMed ID: 20117437
[TBL] [Abstract][Full Text] [Related]
18. Novel mutations in sarcomeric protein genes in dilated cardiomyopathy.
Daehmlow S; Erdmann J; Knueppel T; Gille C; Froemmel C; Hummel M; Hetzer R; Regitz-Zagrosek V
Biochem Biophys Res Commun; 2002 Oct; 298(1):116-20. PubMed ID: 12379228
[TBL] [Abstract][Full Text] [Related]
19. Familial nonsyndromic patent ductus arteriosus caused by mutations in TFAP2B.
Chen YW; Zhao W; Zhang ZF; Fu Q; Shen J; Zhang Z; Ji W; Wang J; Li F
Pediatr Cardiol; 2011 Oct; 32(7):958-65. PubMed ID: 21643846
[TBL] [Abstract][Full Text] [Related]
20. Alpha-tropomyosin mutations in inherited cardiomyopathies.
Redwood C; Robinson P
J Muscle Res Cell Motil; 2013 Aug; 34(3-4):285-94. PubMed ID: 24005378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
